GESTIÓN EN SALUD PÚBLICA: Funding News for global health researchers from the Fogarty International Center at NIH

martes, 2 de junio de 2020

Funding News for global health researchers from the Fogarty International Center at NIH

Fogarty International Center

Funding news for global health researchers and partners from Fogarty at NIH

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

COVID-19 Grants and Funding News

Important news and funding from NIH and others on the novel coronavirus SARS-CoV-2 and coronavirus disease 2019 (COVID-19).

Digital Health Solutions for COVID-19
NIH's National Institute of Biomedical Imaging and Bioengineering (NIBIB) and National Cancer Institute (NCI) require services to develop digital health solutions to address the COVID-19 pandemic and enable new research into using digital health technologies to advance the public health response.
Response deadline: June 5, 2020
COVID-19 Africa Rapid Grant Fund from South Africa’s National Research Foundation
Application deadline: June 17, 2020
Coronavirus Disease 2019 (COVID-19) information for NIH grant applicants and grant recipients, including NIH funding opportunities specific to COVID-19 from the NIH Office of Extramural Research (OER)
Coronavirus news, funding and resources for global health researchers compiled by Fogarty

Funding Opportunities

NIH funding opportunities focusing on global health and foreign collaboration.

Submission deadline extended! NIH Technology Accelerator Challenge: Non-invasive Diagnostic Technologies for Global Health
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) will offer $1,000,000 in prizes to reward and spur the development of platform concepts and prototypes of non-invasive, multiplexed diagnostic technologies for sickle cell disease, malaria and anemia. Fogarty is a partner.
Updated submission deadline: June 16, 2020
Reissue: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) (PA-20-222)
Due dates vary by awarding NIH Institute, Center or Office
Fogarty is participating.
The NIH Common Fund, along with its partner NIH Institutes, Centers and Offices, plans to issue funding opportunity announcements to support Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa). They are expected to be published in Summer 2020, with expected application due dates by November 2020. NIH will host an online-only DS-I Africa Virtual Platform in Summer 2020 to encourage networking across disciplines, sectors and geographies. Please subscribe to the DS-I Africa Listserv to receive the latest information on the DS-I Africa Program and the Virtual Platform.

NIH Notices of Special Interest (NOSIs) that may be of interest to global health researchers.

Notice of Special Interest: Dementia Care Workforce for Those Living with Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) (NOT-AG-20-026)
Notice of Special Interest: Promoting Fundamental and Applied Research in Inflammation Resolution (NOT-ES-20-018)

Information related to opportunities from other organizations focusing on global health and foreign collaboration.

The European and Developing Countries Clinical Trials Partnership (EDCTP) has a number of open calls for proposals to fund collaborative clinical research projects conducted in sub-Saharan Africa on poverty-related infectious diseases.
Application due dates: July and August 2020

Funding News

NIH funding news that may be relevant to global health researchers.

Request for Information (RFI): Advancing Scientific and Workforce Diversity in the BRAIN Initiative (NOT-MH-20-051)
Request for Information (RFI): Input on data sources and data science questions to advance research on alcohol use (NOT-AA-20-013)
Request for Information (RFI): Input to Enhance the Impact of the NCI Experimental Therapeutics Programs Chemical Biology Consortium on Cancer Drug Discovery and Development (NOT-CA-20-071)